CVS Health: Better Times Likely Ahead

JHVEPhoto CVS Health (NYSE:CVS), along with the rest of the healthcare services sector, is having a tough start to 2024. Cyberattacks, regulatory scrutiny, declining COVID-related sales, elections, and lower CMS rates, are colliding with the company's higher medical care costs, implementation struggles, and leadership changes. With so many headwinds, it's natural to expect better times ahead, but is it the right expectation? Let's dive in. Introduction I've been covering CVS on Seeking Alpha since March of ...